The new drug is Repatha™ made by Amgen, and is intended for people with extremely high cholesterol levels and those with heart disease who cannot sufficiently lower their cholesterol levels with statins and other therapies. Repatha will cost $14,100 per year. See links below:
http://www.nytimes.com/2015/08/28/health/fda-approves-another-in-a-new-class-of-cholesterol-drugs.html
https://www.optum.com/thought-leadership/highcostcholesteroldrugs.html
With the cost of these medications going up, its good to know that patients, by volunteering for our clinical trials, actually benefit, by receiving these medications and medical services free, at no cost to the patient.
